Institution
Sun Yat-sen University Cancer Center
Also known as: 中山大学肿瘤防治中心 · SYSUCC
- 565running trials
- 131closed trials
- 29,078publications (OpenAlex)
Running trials
Not yet recruiting
Not yet recruiting
Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma
Recruiting
Not yet recruiting
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer
Not yet recruiting
Not yet recruiting
Recruiting
Anatomic Versus Nonanatomic Liver Resection After Conversion Therapy for Hepatocellular Carcinoma
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Paclitaxel Polymeric Micelles Plus Ivonescimab in Recurrent or Refractory SCLC
Not yet recruiting
Recruiting
A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal Carcinoma
Recruiting
Recruiting
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Standardized MRI and Structured Reporting for Esophageal Squamous Cell Carcinoma
Not yet recruiting
Not yet recruiting
Not yet recruiting
JSKN033 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer.
Recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC
Recruiting
Not yet recruiting
Recruiting
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Recruiting
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
Recruiting
Recruiting
Showing 50 of 565.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer85 recruiting
- Colorectal cancer54 recruiting
- Liver and biliary tract cancer35 recruiting
- Childhood cancers32 recruiting
- Metastatic breast cancer30 recruiting
- Gastric and oesophageal cancer27 recruiting
- Head and neck cancer23 recruiting
- Sarcoma20 recruiting
- Ovarian cancer18 recruiting
- Diffuse large B-cell lymphoma16 recruiting
- Prostate cancer16 recruiting
- Bladder cancer14 recruiting
- Cervical cancer14 recruiting
- Multiple myeloma13 recruiting
- Triple-negative breast cancer13 recruiting
- Pancreatic cancer11 recruiting
- Kidney cancer10 recruiting
- Melanoma10 recruiting
- Endometrial cancer9 recruiting
- Chronic lymphocytic leukaemia7 recruiting
- Mantle cell lymphoma7 recruiting
- Acute myeloid leukaemia6 recruiting
- Neuroblastoma6 recruiting
- Brain metastases5 recruiting
- Glioblastoma4 recruiting
- Neuroendocrine tumours4 recruiting
- Follicular lymphoma3 recruiting
- Acute lymphoblastic leukaemia2 recruiting
- Mesothelioma2 recruiting
- Thyroid cancer2 recruiting
- Amyloidosis1 recruiting
- Hepatitis B1 recruiting
- Hodgkin lymphoma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Neurofibromatosis type 11 recruiting
- Thymoma and thymic carcinoma1 recruiting
Closed trials
Withdrawn
Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer
Completed
Effects of Radiotherapy in Borderline and Malignant Phyllodes Tumors After R0 Resection
Completed
Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
Completed
Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Terminated
Completed
Completed
Adaptive Therapy for Post-Second-Line Advanced Breast Cancer
Withdrawn
Aumolertinib in EGFR-Mutant Resected Stage IB-IIIA NSCLC (AERESA).
Withdrawn
Second-line Treatment With CAdonilimab and LEnvatinib for Unresectable HCC
Recruiting
Completed
Completed
Completed
Completed
Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC
Completed
A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer
Completed
Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer
Terminated
Completed
A Study of Cadonilimab Combined With Regorafenib in Patients With Advanced HCC
Completed
Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
Completed
Completed
Completed
Perioperative Music Therapy Plus Oxycodone in Perioperative Management of Lung Surgery
Completed
Recruiting
Terminated
IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor
Terminated
Completed
Completed
Completed
HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC
Terminated
Completed
Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma
Completed
Completed
Completed
Terminated
Phase I Study of the BBP-398 in Patients With Advance Solid Tumors
Terminated
Completed
Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)
Completed
Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer
Completed
Completed
Completed
Completed
Completed
Completed
Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma
Terminated
A Study of ATG-010 in Combination With Lenalidomide and Rituximab (R2) in Adults With DLBCL and iNHL
Withdrawn
Completed
Completed
Terminated
Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer
Completed
Showing 50 of 131.
Registry name variants (66)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong 510060
576 trials
Sun Yat-Sen University Cancer Center
Guangdong, 510060
16 trials
Cancer Center, Sun Yat-sen University
Guangzhou, Guangdong 510060
12 trials
Sun Yat-sen University Cancer Center
Guanzhou, Guangdong 510060
11 trials
Sun Yat-Sen University Cancer Centre
Guangzhou, Guangdong 511400
7 trials
Sun Yat-sen University Cancer Center (SYSUCC)
Guangzhou, Guangdong 510075
6 trials
Sun Yat-Sen University Cancer Center - Huangpu Campus
Guangzhou, 510060
5 trials
Cancer center of Sun Yat-sen University
Guangzhou, Guangdong 510060
4 trials
Medical Oncology,Sun Yat-sen University Cancer Center
Guangzhou, Guangdong 510060
4 trials
Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center
Guangzhou, Guangdong 510060
3 trials
Contact: Jihong Liu, Ph.D.
NCT04710797Lymphadenectomy in Early Ovarian Cancer
Contact: Jihong Liu, Ph.D.
Department of Medical Oncology,Cancer Center of Sun Yat-Sen University
Guangzhou, Guangdong 510060
2 trials
Contact: Li Zhang, MD
Department of Radiation Oncology, Sun Yat-sen University Cancer Center
Guangzhou, Guangdong 510060
2 trials
Contact: Fang-Yun Xie, Principal Investigator
NCT06829147A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)
Contact: Pu-Yun OuYang
Sun Yat-sen University Cancer Center
Guandong, 510060
2 trials
Sun Yat-Sen University Cancer Center (Site 1150)
Guangzhou, Guangdong 510060
2 trials
SUN YAT-SEN UNIVERSITY CANCER CENTRE (Site 6003)
Guangzhou, Guangdong 510060
2 trials
Department of Medical Oncology, Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong 510060
1 trial
Contact: Zhiming Li, MD
Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center
Guangzhou, Guangdong 500060
1 trial
Department of Thoracic Surgery, Sun Yat-sen University Cancer Center
Guangzhou, Guangdong 510060
1 trial
NCT07309991Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy
Contact: Hong Yang, M.D.
Minimally Invasive Interventional Division, Medical Imaging Center, Sun Yat-sen University Cancer Center,
Guangzhou, Guangdong 500060
1 trial
Sun Yat-sen University Cancer Center
Shanghai
1 trial
Contact: Xuzhi Pan
Sun Yat-sen University Cancer Center
Yuexiucun, Guangzhou 510060
1 trial
Sun Yat-sen University Cancer Center
Zhongshan
1 trial
NCT06214156A Clinical Study of T3011 in Subjects With Advanced Melanoma
Contact: Xiaoshi Zhang
Sun Yat-Sen University Cancer Center (0602)
Guangzhou, Guangdong 510000
1 trial
Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou 510060, P. R. China
Guangzhou, Guangdong 510000
1 trial
Sun Yat-Sen University Cancer Center - Cancer Prevention and Treatment Center, Sun Yat-sen University
Guangzhou, Guangdong 510000
1 trial
Sun Yat-Sen University Cancer Center;Department of Thoracic Surgery
Guangzhou, 510050
1 trial
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong 510060
1 trial
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong 510060
1 trial
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong 510060
1 trial
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong 510060
1 trial
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong 510060
1 trial
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong 510060
1 trial
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong 510060
1 trial
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong 510060
1 trial
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong 510060
1 trial
Sun Yat-sen University Cancer Center (Site 0047)
Guangzhou, Guangdong 510060
1 trial
Sun Yat-Sen University Cancer Center (Site 0183)
Guangzhou, Guangdong 510060
1 trial
Contact: Study Coordinator
Sun Yat-Sen University Cancer Center (Site 0188)
Guangzhou, Guangdong 510060
1 trial
Contact: Study Coordinator
Sun Yat-Sen University Cancer Center (Site 0417)
Guangzhou, Guangdong 510060
1 trial
Sun Yat-sen University Cancer Center (Site 0500)
Guangzhou, Guangdong 510060
1 trial
Sun Yat-Sen University Cancer Center (Site 0602)
Guangzhou, Guangdong 510000
1 trial
Sun Yat-Sen University Cancer Center (Site 0800)
Guangzhou, Guangdong 510060
1 trial
Contact: Study Coordinator
Sun Yat-Sen University Cancer Center (Site 0816)
Guangzhou, Guangdong 510060
1 trial
Sun Yat-Sen University Cancer Center (Site 0825)
Guangzhou, Guangdong 510060
1 trial
Sun Yat-sen University Cancer Center (Site 0846)
Guangzhou, Guangdong 510060
1 trial
Sun Yat-sen University Cancer Center (Site 1201)
Guangzhou, Guangdong 510060
1 trial
Sun Yat-sen University Cancer Center (Site 1409)
Guangzhou, Guangdong 510300
1 trial
Contact: Study Coordinator
Sun Yat-Sen University Cancer Center (Site 1467)
Guangzhou, Guangdong 510060
1 trial
Contact: Study Coordinator
Sun Yat-sen University Cancer Center (Site 1604)
Guangzhou, Guangdong 510555
1 trial
Sun Yat-sen University Cancer Center (Site 1608)
Guangzhou, Guangdong 510700
1 trial
Sun Yat-Sen University Cancer Center (Site 1712)
Guangzhou, Guangdong 510060
1 trial
NCT07519772A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Contact: Study Coordinator
Sun Yat-sen University Cancer Center (Site 1905)
Guangzhou, Guangdong 510060
1 trial
Contact: Toll Free Number
Sun Yat-sen University Cancer Center (Site 2028)
Guangzhou, Guangdong 510060
1 trial
Sun Yat-sen University Cancer Center (Site 2134)
Guangzhou, Guangdong 510060
1 trial
Contact: Study Coordinator
Sun Yat-Sen University Cancer Center (Site 3001)
Guangzhou, Guangdong 510060
1 trial
Sun Yat-Sen University Cancer Center (Site 3102)
Guangzhou, Guangdong 510060
1 trial
NCT07060807A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Contact: Study Coordinator
Sun Yat-sen University Cancer Center (Site 3121)
Guangzhou, Guangdong 510060
1 trial
Contact: Study Coordinator
Sun Yat-sen University Cancer Center (Site 3137)
Guangzhou, Guangdong 510555
1 trial
Sun Yat-Sen University Cancer Center (Site 5014)
Guangzhou, Guangdong 510060
1 trial
Sun yat-sen university cancer center, Sun yat-sen university
Guangzhou, Guangdong 51000
1 trial
Contact: Qingqing Cai
Sun Yat-Sen University Cancer Center(Yuexiu Campus)
Guangzhou, Guangdong 510060
1 trial
Contact: Shushen Wang, Ph.D
SUN YAT-SEN UNIVERSITY CANCER CENTRE (Site 0710)
Guangzhou, Guangdong 510700
1 trial
SUN YAT-SEN UNIVERSITY CANCER CENTRE (Site 1406)
Guangzhou, Guangdong 510060
1 trial
SUN YAT-SEN UNIVERSITY CANCER CENTRE (Site 1600)
Guangzhou, Guangdong 510060
1 trial
SUN YAT-SEN UNIVERSITY CANCER CENTRE (Site 1752)
Guangzhou, Guangdong 510060
1 trial
Sun Yat-sen University of Cancer Center
Guangzhou, Guangdong 510060
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Lung cancer222 works · 148 trials
- Liver and biliary tract cancer193 works · 57 trials
- Colorectal cancer144 works · 75 trials
- Gastric and oesophageal cancer110 works · 46 trials
- Triple-negative breast cancer49 works · 25 trials
- Ovarian cancer47 works · 28 trials
- Bladder cancer47 works · 24 trials
- Cervical cancer41 works · 23 trials
- Melanoma38 works · 17 trials
- Brain metastases37 works · 8 trials
- Kidney cancer34 works · 19 trials
- Glioblastoma27 works · 8 trials
- Sarcoma26 works · 24 trials
- Metastatic breast cancer21 works · 47 trials
- Endometrial cancer21 works · 13 trials
- Diffuse large B-cell lymphoma20 works · 28 trials
- Hodgkin lymphoma19 works · 4 trials
- Thyroid cancer17 works · 6 trials
- Head and neck cancer15 works · 31 trials
- Thymoma and thymic carcinoma14 works · 1 trial
- Hypothyroidism13 works · 0 trials
- Neuroblastoma10 works · 7 trials
- Myasthenia gravis8 works · 0 trials
- Mantle cell lymphoma6 works · 18 trials
- Chronic myeloid leukaemia5 works · 1 trial
- Testicular cancer3 works · 0 trials
Institution data: ROR 0400g8r85 (CC0-1.0)Updated 15 Nov 2026